- In February 2024, Allderma AB introduced the Terclara brand for the sale of MOB-015, effective in the treatment of onychomycosis across the European region.
- In December 2021, Bausch Health Companies Inc. revealed that JUBLIA (efinaconazole) Topical Solution, 10%, a remedy for onychomycosis, was awarded the American Podiatric Medical Association (APMA) Seal of Approval as it enhances foot health.
- In February 2021, Lupin Limited was granted approval by the US Food and Drug Administration for its Tavaborole Topical Solution indicated for onychomycosis.
